Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Hereditary Podocytopathies, Alport Syndrome, and FSGS: A Case Series to Better Plan a Large-Scale Study

Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Hereditary Podocytopathies, Alport Syndrome, and FSGS: A Case Series to Better Plan a Large-Scale Study

Hereditary diseases of the glomerular filtration barrier are characterized by a more vulnerable glomerular basement membrane and dysfunctional podocytes. Recent clinical trials have demonstrated the nephroprotective effect of sodium-glucose cotransporter-2 inhibitors (SGLT2i) in chronic kidney disea...

Full description

Bibliographic Details
Main Authors: Jan Boeckhaus, Oliver Gross
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Cells
Subjects:
podocytopathies
hereditary kidney diseases
Alport syndrome
focal segmental glomerulosclerosis
kidney therapies
nephroprotection
Online Access:https://www.mdpi.com/2073-4409/10/7/1815

Internet

https://www.mdpi.com/2073-4409/10/7/1815

Similar Items